• Because of the enhanced antiinflammatory efficacy and the lower incidence of gastric toxicity, the development of dual inhibitors of COX-2 and 5-LOX pathways may represent a new strategy to fight severe sepsis. This evidence concerns the gene ALOX5 and Sepsis.